Knight Therapeutics Inc.
KHTRF
$4.32
-$0.05-1.19%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4,517.98% | -542.81% | 145.15% | 142.89% | -99.13% |
| Total Depreciation and Amortization | 31.41% | -8.84% | -13.50% | 19.85% | -3.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | 2.25% | -- |
| Total Other Non-Cash Items | 195.90% | 2,111.75% | -81.72% | -142.00% | 381.59% |
| Change in Net Operating Assets | -2.58% | 207.65% | -169.83% | -324.29% | -49.41% |
| Cash from Operations | 100.64% | 1,944.21% | -88.84% | -92.04% | -67.48% |
| Capital Expenditure | -8.57% | 10.88% | 61.41% | -23.42% | -62.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -51.40% | -94.95% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -81.69% | -50.61% | 229.71% | 631.59% | -67.47% |
| Cash from Investing | -112.08% | -952.38% | 223.86% | 1,022.76% | -68.30% |
| Total Debt Issued | -- | 14,544.44% | 231.93% | -- | -39.47% |
| Total Debt Repaid | -65.02% | -606.28% | -3.72% | 34.14% | 9.37% |
| Issuance of Common Stock | -71.88% | 6.76% | 54.05% | 47.37% | 409.09% |
| Repurchase of Common Stock | -- | 99.52% | -- | 73.01% | 74.84% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -103.78% | 7.19% | 37.13% | 36.70% | 40.82% |
| Cash from Financing | -49.01% | 542.29% | -52.37% | 58.20% | 65.64% |
| Foreign Exchange rate Adjustments | 261.54% | -204.85% | 96.13% | 112.76% | 399.38% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -68.95% | -1,574.59% | 639.00% | 133.08% | -67.82% |